Common Haematological Problems in Primary Care

Size: px
Start display at page:

Download "Common Haematological Problems in Primary Care"

Transcription

1 23 rd March 2019 GP Hot Topics In Primary Care Common Haematological Problems in Primary Care Dr Samar Kulkarni Consultant Haematologist-Oncologist and The Christie Private Care Manchester, UK.

2 Haematology? Haematology is the study of formed elements in blood including The white blood cells (leukocytes) The red blood cells (erythrocytes) The platelets (thrombocytes) All are derived from pluripotent stem cell in the bone marrow Bone marrow is the predominant site of pathology

3 RBCs Disorders Anaemias &Others WBC Disorders Benign & Malignant Hematological Disorders Haemostatic Disorders Transfusion Medicine

4 Overview of Haematological indices Anaemia Leucocytosis & Lymphocytosis Neutropenia Thrombocytopenia Paraprotein

5 Definition of Anaemia Anaemia is a functional inability of the blood to supply the tissue with adequate O 2 for proper metabolic function Anaemia is not a disease, but rather the expression of an underlying disorder or disease

6 Diagnosis of anemia Complete blood count, CBC, will include: An RBC count: At birth: x 10 9 /L Males: x 10 9 /L Females: is x 10 9 /L Hematocrit (Hct) or packed cell volume in % or At birth: 42-60% (42-60) Males: 41-53% (41-53) Females: 38-46% (38-46)

7 CBC and RBC indices fl pg g/dl %

8 The Three Derived Indices Measurement Normal Range A. RBC count 5 million 4 to 6 B. Hemoglobin 15 g% 12 to 17 C. Hematocrit to 50 A x 3= B x 3 = C (if not then micro or macrocytosis or hypochromia) MCV C A x 10 = 90 fl MCH B A x 10 = 30 pg MCHC B C x 100 = 33%

9 Diagnosis of Anaemia Hemoglobin concentration in grams/l At birth the normal range is g/l The normal range for males is g/l The normal range for females is g/l RBC indices Use results of the RBC count, hematocrit, and hemoglobin to calculate 4 parameters: Mean corpuscular volume (MCV) is the average volume/rbc in femtoliters (10-15 L) Hct (in %)/RBC (x /L) x 10 At birth the normal range is In adults the normal range is

10 Diagnosis of Anaemia Mean corpuscular hemoglobin (MCH) is the average weight of hemoglobin/cell in picograms (pg= g) Hgb (in g/dl)/rbc(x /L) x 10 At birth the normal range is In adults the normal range is Red cell distribution width (RDW) is a measurement of the variation in RBC cell size Standard deviation/mean MCV x 100 The range for normal values is % A value > 14.5 means that there is increased variation in cell size above the normal amount (anisocytosis) A value < 11.5 means that the RBC population is more uniform in size than normal.

11 Diagnosis of Anaemia The MCV is used to classify RBCs as: Normocytic (80-100) Microcytic (<80) Macrocytic (>100) Mean corpuscular hemoglobin concentration (MCHC) is the average concentration of hemoglobin in g/dl (or %) Hgb (in g/dl)/hct (in %)x 100 At birth the normal range is In adults the normal range is The MCHC is used to classify RBCs as: Normochromic (31-37) Hypochromic (<31)

12 Mean Cell Volume (MCV) RBC volume is measured by The Mean Cell Volume or MCV and RDW MCV Microcytic < 80 fl Normocyti Macrocytic c fl > 100 fl < 6.5 µ µ > 9 µ

13 Approach to Anemia CBC Reticulocyte count MCV RI < 2% RI > 2% Underproduction Increased destruction or loss MCV < 80 Microcytic MCV MCV Normocytic MCV > 100 Macrocytic Further work up Based on history, Physical, other

14 The definitive test is serum ferritin Low serum ferritin (<12 ug/l)is diagnostic of iron deficiency Although ferritin is an acute phase reactant, it will still be low in iron deficiency Also, high TIBC Fe saturation = Fe/TIBC < 10% in Fe deficiency If ferritin is indeterminate Low serum Fe is not in itself diagnostic, neither is marrow staining Anisocytosis (heterogeneous in shape) and poikilocytosis (abnormal shape) Reactive thrombocytosis Iron Deficiency Anemia

15 Macrocytic Anemia (MCV>100) Drug Induced (hydroxyurea, AZT, MTX, chemotherapy, anticonvulsants) B12 / folate deficiency Myelodysplastic syndrome Liver disease Alcohol abuse Reticulocytes Hypothyroidism

16 Leucocytosis Leucocytosis does not mean haematological malignancy Careful history Fevers, diarrhoea, drugs, smoking Examine Skin, liver, spleen, lymph nodes Ask for a blood film What is the white cell differential? What do the white cells look like? Is the rest of the FBC normal? Consider repeating the blood count 2-4 weeks.

17 Lymphocytosis Lymphocyte Count Investigation >10 x 10 9 /L Refer to haematology for investigation >3.5 and <10 x 10 9 /L Rest of blood count normal No lymphadenopathy or splenomegaly >3.5 and <10 x 10 9 /L and anaemia or thrombocytopenia or lymphadenopathy or splenomegaly Repeat FBC and Blood film in 3-6 months: If lymphocytes are lower or the same level: no further investigation or monitoring; repeat blood count in 1 year If lymphocytes are > 10 x10 9 /L: refer to haematology for investigation Refer to haematology for investigation

18 Asymptomatic lymphocytosis Early CLL - Stage A Normal Hb, neutrophils, platelets, no organomegaly Does not require treatment (usually) Increased risk of bacterial infection and zoster Annual flu vaccination and consider for Pneumovax May increase risk of other malignancies Clinical assessment and monitor blood count every few months initially

19 Chronic Lymphocytic Leukaemia (CLL) Accumulation of mature B cells Commonest leukaemia (4/100,000/year) Symptoms/signs often none, found on routine FBC May have enlarged rubbery non tender lymphadenopathy, hepato/spleomegaly and systemic symptoms Investigations Flow-cytometry, can cause autoimmune haemolysis and pancytopenia

20 Isolated Neutropenia Severity Categories of Neutropenia Severity Neutrophil Count Mild x10 9 /L Moderate x10 9 /L Severe <0.5 x10 9 /L

21 Causes of Neutropenia Transient Viral infections neutropenia usually lasts 2 weeks and rarely cause clinical problems Occasionally, the neutropenia may persist for months. Persistent Benign ethnic neutropenia Individuals of African-Caribbean or Middle Eastern descent Viral infections EBV, HIV, hepatitis Autoimmuine disorders Drugs Splenomegaly ( +liver disease) Haematological diseases Myelodysplasia, leukaemia, lymphoma, myeloma, B12/folate deficiency etc. Rare congenital

22 Evaluation of a patient with Neutropenia History: Symptoms or history of recurrent infection Drug history Family history of infections Records of past FBCs (chronicity of the neutropenia) Risk factors for HIV, TB Examination: Signs of infection: oral mucosa, skin rashes, abscesses, lung infections, perianal/genital area Splenomegaly Other signs of underlying medical problems (SLE, malignancy)

23 Investigations: Evaluation of Neutropenia Repeat FBC with differential Blood film (do the cells look normal?) Paul Bunnell (IMST) B12, folate Autoantibody screen & rheumatoid factor HIV testing if clinical risk factors are present Blood cultures if the patient is pyrexial (in which case send to hospital)

24 First checks- When to seek further advice or refer to Haematology? How severe is the neutropenia? Are there any other abnormalities of the blood count? Does the patient have any symptoms relating to the neutropenia? How long has the neutropenia persisted for? Consider referral if- Persistent neutropenia <1.3 x 10 9 /L over 6-8 weeks with no obvious cause Neutropenia associated with severe and/or recurrent infection Neutropenia associated with other full blood count abnormalities Neutropenia associated with splenomegaly (NOT due to liver disease fulfils 2 week wait criteria) Suspected underlying haematological disease: i.e. clinical symptoms or on blood film

25 Thrombocytopenia Normal count (x10 9 /L) Mild Moderate Severe <30 Consider Is the low platelet count acute or chronic? Are there associated abnormalities of other blood counts? Has the FBC been repeated? Does the patient have a history suggestive of infection, autoimmune disease, or malignancy?

26 Thrombocytopenia Medication history (the list is endless!)? Examine for spleen, lymph nodes, skin rashes, musculoskeletal abnormalities Request blood film: Platelet clumping May-Hegglin (large platelets that machine doesn t count) Hypersegmented neutrophils & macrocytosis (B12 / folate deficiency) Lymphocytosis etc. -? CLL Macrocytosis and Pelgeroid neutrophils - MDS

27 Thrombocytopenia Isolated thrombocytopenia, normal blood film and physical examination: bone marrow test may not be necessary If patient is asymptomatic: monitoring with serial blood counts is required Most patients with isolated mild thrombocytopenia do not develop clinical disease Those that do, the commonest group is autoimmune in origin Consider HIV and Hepatitis C as an underlying cause without other explanation

28 Leukaemia Acute leukemia is characterized by an abnormal proliferation of immature white blood cells, called blasts or progenitor cells Two main forms of acute leukemia Acute lymphoblastic leukemia A cancer at the earliest stages of lymphocyte maturation Occurs more often in the young Acute nonlymphoblastic leukemia Usually a malignancy of the myeloblast More common in adults

29 A B C D A : Picture of bone marrow smear (control) B : Acute lymphoid leukemia (ALL); Proliferation of small lymphoblasts. C : Acute myeloid leukemia (AML); Proliferation of large myeloblasts. D : Chronic myeloid leukemia (CML); Proliferation of granulocytes at various stages of maturation.

30 Functional Presentation of Leukaemia Leukaemia present with signs and symptoms of Anaemia Neutropenia with infection and fever Thrombocytopenia with bleeding Patients may present critically unwell

31 Physical Findings Fever Pallor Icterus Bruising/Bleeding Lymphadenopathy Liver or spleen enlargement Generally unwell

32 Disorder Associated with Monoclonal Protein Neoplastic cell proliferation Multiple myeloma Solitary plasmacytoma Waldenstrom macroglobulinemia Heavy chain disease Primary amyloidosis Undetermined significance Monoclonal gammopathy of undetermined significance (MGUS) Transient M protein Viral infection Post-valve replacement Malignacy Bowel cancer, Breast cancer Immune dysregulation HIV, Old age Chronic inflamation

33 Paraproteins Does the patient have symptoms? Does the patient have clinical signs (e.g. nodes)? How high is the paraprotein concentration? What sort of paraprotein is it? IgA / IgG ~ Myeloma IgM / IgG ~ Lymphoma Are the other Igs suppressed? Is the blood count normal? Are the renal function and calcium normal? Most paraproteins are incidental and usually represent MGUS

34 Monoclonal Gammopathy of Undetermined Significance (MGUS) Common, age-related Prevalence: 3.2% in persons over 50 yrs old (Minnesota) Approximately 5% in age above 70yr Higher prevalence in African populations.? Association with inflammatory states: obesity, Gaucher s disease Increased risk for thrombosis and fractures Risk of progression in entire population: 1% per year Risk factors for progression: %PC, level M spike, raised free light chain, IgA protein,?decline in uninvolved Ig s

35 Probability of Progression among 1384 Residents of Southeastern Minnesota in Whom Monoclonal Gammopathy of Undetermined Significance (MGUS) Was Diagnosed from 1960 through 1994 Kyle, R. A. et al. N Engl J Med 2002;346: Risk of progression to serious disease 1% per year

36 1% of people > 50 yrs age 10% of people > 80 yrs age 10% will develop myeloma How to monitor? MGUS: How to Monitor 6 monthly FBC, U&E, calcium, and paraprotein quantitation Refer to haematology if- Falling Hb, Rising urea or calcium, Rising paraprotein, bone pain, lymphadenopathy

37 Criteria for Diagnosis MGUS <3 g M spike <10% PC Smoldering MM 3 g M spike OR 10% PC Active MM 10% PC M spike + AND AND CRAB Negative CRAB: Positive CRAB: Calcium, Renal, Anaemia, Bones Kyle RA. N Engl J Med 2002; 346: 564

38 Myeloma Malignant clonal proliferation of plasma cells Incidence 5/100,000, peak age 70 years Symptoms and signs: - Osteolytic bone lesions backache, pathological fractures. - Hypercalcaemia - Anaemia, thrombocytopenia, neutropenia - Recurrent bacterial infections - Renal impairment (light chain deposition) - Can present acutely with cord compression, hyperviscocity or renal failure.

39 Number of cases 0-4 How common is it in UK? 1% of All Cancers 2 nd common Haematological Malignancy Rate per 100,000 population per 100,000 Numbers of new 3-4 cases cases and in age 35 yr./gp specific Surgery incidence rates, Male cases Female cases Male rates Female rates Age at diagnosis

40 Clinical presentation

41 Diagnostic Evaluation History and physical examination Blood work-up Full blood count Urea, Creatinine, Calcium, Albumin Serum protein electrophoresis (SPEP) and immunofixation Serum free light chains 2 -microglobulin Urine Bence Jone Protein Skeletal survey Bone marrow examination with cytogenetics

42 Myeloma

43 International Staging System (ISS) For Symptomatic Myeloma Stage I Criteria β2m < 3.5 mg/l albumin 3.5 g/dl Median Survival (mo) 62 II* Not stage I or III 44 III β2m 5.5 mg/l 29 *β2m < 3.5 mg/l and albumin < 3.5 g/dl or β2m < 5.5 mg/l, any albumin Greipp et al. J Clin Oncol 2005; 23:

44 Survival Impact of Novel Agents on the Outcome in Post ASCT Relapsed/refractory Disease (n=387) Relapsed before 1998 Relapsed Relapsed Relapsed Relapsed P< Time (months) Kumar et al Blood 2008

45 Impact of New Drugs on Survival in BC Date of Diagnosis % alive at 5 years Before % 2003 and beyond 70%

46 Myeloma Drugs Drug Year of Approval (USA) Monthly Medicare Price at time of Approval Melphalan Bortezomib Lenalidomide Thalidomide Daratumomab Ixazonib

47 Suspected Haematological Cancers Combinations of the following symptoms and signs may suggest haematological cancer Fatigue Drenching night sweats Fever Weight loss Generalised pruritus Breathlessness Bruising Bleeding Recurrent infections Bone pain Alcohol-induced pain Abdominal pain Lymphadenopathy Splenomegaly Hepatomegaly

48 If unsure what to do or a Haematology patient is unwell, never hesitate to contact haematologist day or night

49 CBC Components Red Blood Cells (RBCs) Haematocrit (Hct) Haemoglobin (Hgb) Mean Corpuscular Volume (MCV) Mean Corpuscular Haemoglobin(MCH) Mean Corpuscular Haemoglobin Concentration (MCHC) Red cell distribution width (RDW) White Blood Cells (WBCs) Platelets Mean Platelet Volume (MPV)

50 Neutropenia The severity of neutropenia is categorised as Severity Neutrophil count (x10 9 /L) Mild Moderate Severe <0.5

51 Causes of Neutropenia Transient Viral infections: usually lasts 2 week seldom any clinical problems Occasionally may persist for months Persistent Benign ethnic neutropenia- African-Caribbean or Middle Eastern descent Viral infections : EBV, HIV, hepatitis Autoimmune disorders: SLE, RA Drugs: A long list! Splenomegaly Haematological diseases: MDS, leukaemia, lymphoma, myeloma, B12/folate deficiency

52 Evaluation of a patient with neutropenia History: History of recurrent infection? Drug history Family history of infections Records of past FBCs to establish the chronicity of the neutropenia Risk factors for HIV, TB Examination: Signs of infection: oral mucosa, skin rashes, abscesses, lung infections, perianal/genital area Splenomegaly Other signs of causative medical problems (SLE, malignancy)

53 First check: How severe? Neutropenia When to seek advice or refer to Haematology? Any other abnormalities of the blood count? Any symptoms relating to the neutropenia? How long has it persisted? Consider referral if: Persistent neutropenia <1.3 x 10 9 /L over 6-8 weeks Associated severe and/or recurrent infection Associated other full blood count abnormalities Associated splenomegaly (NOT due to liver disease fulfils 2 week wait criteria) Suspected underlying haematological disease clinical symptoms

54 If unsure what to do or a Haematology patient is unwell, never hesitate to contact haematologist day or night

Hematology 101. Rachid Baz, M.D. 5/16/2014

Hematology 101. Rachid Baz, M.D. 5/16/2014 Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group GP Referral Guidelines for South Wales Cancer Network Document Control Sheet Organisation South Wales Cancer Network Specialty/Project Haematological Site Specific Group Document Title GP Referral Guidelines

More information

Haematological Cancer Suspected (Adults & Children)

Haematological Cancer Suspected (Adults & Children) Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years

More information

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed

More information

Anaemias and other Pesky Haematology Questions

Anaemias and other Pesky Haematology Questions Anaemias and other Pesky Haematology Questions 3 main topics How do I work out an anaemia.. That oh too common paraprotein patient. Those mildly raised lymphocyte count GP discussed patient with me over

More information

Michael Joffe ST6 Haematology SpR

Michael Joffe ST6 Haematology SpR Michael Joffe ST6 Haematology SpR Mrs SB 71 year old female on AMU Telephone referral to haematology by medicine with Hb 102 MCV 89, normal B12, Folate, Ferritin. PMH DM General decline over several weeks

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

FBC interpretation. Dr. Gergely Varga

FBC interpretation. Dr. Gergely Varga FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

GP CME. James Liang Consultant Haematologist. Created by: Date:

GP CME. James Liang Consultant Haematologist. Created by: Date: GP CME James Liang Consultant Haematologist Date: Created by: Scenario 52 year old European male Fit and well Brother recently diagnosed with diabetes PMHx Nil Social Hx Ex-smoker stopped 5 years ago (20

More information

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC Evaluation of Anemia Md. Shafiqul Bari Associate professor (Medicine) SOMC Definition Anemia is operationally defined as a reduction in one or more of the major RBC measurements Hemoglobin concentration

More information

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals I. Definitions II. III. Red blood cell life cycle Iron metabolism IV. Causes of anemia A. Kinetic approach 1. decreased production 2. increased destruction 3. blood loss B. Morphologic approach 1. normocytic

More information

The Complete Blood Count

The Complete Blood Count The Complete Blood Count (Cartesian Thinking at Its Best) A SEM Image of Normal Human Blood Laurie Larsson February 22, 2010 Anatomy and Philology II Dr. Danil Hammoudi Introduction A complete blood count

More information

Problem Based Learning

Problem Based Learning Problem Based Learning 2 Dania Qarqash&OmaymaHassanin Enas Ajarma Dr.Hikmat Abdel-Razeq Clinical hematology is divided into four subjects : 1- Benign hematology Anemia Benign WBC disorders Bone marrow

More information

Western Health Specialist Clinics Access & Referral Guidelines

Western Health Specialist Clinics Access & Referral Guidelines Haematology Specialist Clinics at Western Health: Western Health runs MBS funded Specialist Clinics on a Wednesday and Thursday afternoon at its Sunshine Hospital site for patients who require assessment

More information

Year 2003 Paper two: Questions supplied by Tricia

Year 2003 Paper two: Questions supplied by Tricia QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]

More information

2013 AAIM Pathology Workshop

2013 AAIM Pathology Workshop 2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone

More information

Diseases Of The Blood

Diseases Of The Blood Diseases Of The Blood DR. Associate Professor Of Pathology Faculty Of Medicine Ain Shams University Red Blood Cells and Anemia RBC=4-6 million/mm 2 Hb=12-18 g/dl Oxygen Carrying Molecule Hemoglobin Tetramer:

More information

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology 1 Version control: There are two controlled versions of this document, one for GSTT and one for KCH. While

More information

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for

More information

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore HAEMATOLOGICAL EVALUATION OF ANEMIA Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore Learning Objectives Laboratory tests for the evaluation of anemia

More information

Clinical & Laboratory Assessment

Clinical & Laboratory Assessment Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment

More information

namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES

namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF BIOMEDICAL SCIENCES QUALIFICATION CODE: SOBBMS LEVEL: 6 COURSE

More information

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES r). nnmlbih UNIVERSITY OF SCIEFICE nnd TECHNOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF MEDICAL LABORATORY SCIENCES QUALIFICATION CODE: 08BMLS

More information

Haematology dilemma s to refer or not to refer?

Haematology dilemma s to refer or not to refer? Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer

More information

Platelet and WBC disorders

Platelet and WBC disorders Division of Family Practice Platelet and WBC disorders Adrian Yee MD FRCPC Clinical hematologist Assistant Dean, undergraduate education, IMP asyee@uvic.ca When we understand that slide, we'll have won

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis

More information

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance)

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance) Southern Derbyshire Shared Care Pathology Guidelines MGUS (Monoclonal Gammopathy of Undetermined Significance) Purpose of guideline This guideline provides information about the risk stratification of

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008 MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood

More information

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology For two week wait pathway, please continue to use existing documentation/pathways. Telephone advice and guidance

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + Disclosures Advisory Boards: AMGEN, Lundbeck, NOVARTIS + Subtypes of Plasma Cell Disorders Increased Plasma

More information

Interpreting Blood Tests Part 1. Dr Andrew Smith

Interpreting Blood Tests Part 1. Dr Andrew Smith Interpreting Blood Tests Part 1 Dr Andrew Smith Outline Part 1 (This Week) Introduction Which Tube!?! FBCs U+Es Part 2 (Next Week): More Electrolytes LFTs Clotting Extras Introduction Bloods are a core

More information

Deconstructing the CBC

Deconstructing the CBC Deconstructing the CBC Dr. Ann M. Wexler Solano Hematology Oncology September 10, 2017 What Are the Major Components of Blood? Red Blood Cells (also called erythrocytes) White Blood Cells (also called

More information

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist Borderline cytopenias Dr Taku Sugai Consultant Haematologist Borderline cytopenias Neutropenia Thrombocytopenia Anaemia with normal haematinics Two recent cases of cytopenias Neutropenia ANC of more than

More information

Symptoms and Signs in Hematology (2)/ 2013

Symptoms and Signs in Hematology (2)/ 2013 Symptoms and Signs in Hematology (2)/ 2013 Abdallah Abbadi.MD.FRCP Professor of Medicine,Hematology & Oncology University of Jordan & JUH Email: abdalla.awidi@gmail.com Case one: A 24 yr old female complains

More information

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired Interpreting the CBC Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired The CBC 3 Cell Lines RBCs WBCs Platelets Assess general health Make

More information

Disorders of Blood Cells & Blood Coagulation

Disorders of Blood Cells & Blood Coagulation Disorders of Blood Cells & Blood Coagulation HIHIM 409 WBC count RBC count WBC differential Hemoglobin (HGB) Hematocrit (HCT) % of volume occupied by RBCs CBC Red cell indices Mean cell volume (MCV) average

More information

Aplastic anamia & Sideroblastic anemia

Aplastic anamia & Sideroblastic anemia Hematology Lecture 7 كلية التقنيات الصحية والطبية قسم التحليالت المرضية Aplastic anamia & Sideroblastic anemia اإلعداد: ظفر جبار دهاق فؤاد APLASTIC ANEMIA What is Aplastic anemia? Aplastic anemia is a

More information

Smoldering Multiple Myeloma. A Case Study

Smoldering Multiple Myeloma. A Case Study Smoldering Multiple Myeloma A Case Study Case Presentation 53-Year-Old Male Patient presented for a routine exam No prior history of disease or family history of fhematologic disorders d or malignancies,

More information

Adult Acute leukemia. Matthew Seftel. August

Adult Acute leukemia. Matthew Seftel. August Adult Acute leukemia Matthew Seftel August 21 2007 mseftel@cancercare.mb.ca Principles 3 cases Diagnosis and classification of acute leukemia (AL) Therapy Emergencies Remission induction BMT Complications

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph

More information

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Candidates must answer ALL questions

Candidates must answer ALL questions Time allowed: Three hours. Part 1 examination Haematology: First paper Tuesday 22 March 2016 Candidates must answer ALL questions Question 1: General Haematology A 16 year old non-european is referred

More information

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital Approach to the child with anemia Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital Definition of anemia Hb< 2 SD or P2.5 below the mean for a healthy of the same gender

More information

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly

More information

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor Email: abdalla.awidi@gmail.com Main Hematological diseases A- Benign Hematology 1- Anemias 2- Bleeding disorders

More information

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH Cytopaenias in HIV Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH Introduction Cytopaenias in HIV are common Anaemias multifactorial causes Thrombocytopaenias may be the first

More information

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma Fifth stage Lec-14 د.خالد نافع Medicine 24/4/2016 Multiple Myeloma Plasma cell myeloma Variants Non - secretory myeloma Indolent myeloma Smouldering myeloma Plasma cell leukaemia Plasmacytoma - Solitary

More information

The LaboratoryMatters

The LaboratoryMatters Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. Complete Blood Count This issue highlights: CBC, while ubiquitous, is an excellent diagnostic

More information

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous

More information

Blood Cancers in the Community

Blood Cancers in the Community Over to you, mate Blood Cancers in the Community National Rural Health Conference NZ Rural General Practice Network April 7, 2018 Brian Grainger Haematology Registrar Auckland Acknowledgements Dr James

More information

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous

More information

Hematology Case Conference 8/5/03

Hematology Case Conference 8/5/03 Hematology Case Conference 8/5/03 Bone Marrow Case Patient: Emmxxx Lylexxx 74 year old AA female S/P craniotomy for SDH. Pt has Hx of HTN, DM, Crohn s disease, (R) nephrectomy. Bone marrow for abnormal

More information

Case #1. Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute

Case #1. Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute Case #1 Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute Patient History Part I 76 year-old man 1997 diagnosed with MGUS (biclonal) during evaluation of (self-limited) anemia.

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

Mr Matthew Eby. Dr Humphrey Pullon

Mr Matthew Eby. Dr Humphrey Pullon Dr Humphrey Pullon Haematologist Hamilton Mr Matthew Eby Senior Support Services Coordinator Leukaemia & Blood Cancer Foundation New Zealand Hamilton 16:30-17:25 WS #64: Managing Haemopoetic Disease in

More information

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist Hematology 101 Cindy Rogers, MT(ASCP) Diagnostics System Specialist More Acronyms...» CBC» RBC» HGB» HCT» WBC» MPV» PLT» RDW» DIFF» H&H» Complete Blood Count» Red Blood Cell» Hemoglobin» Hematocrit» White

More information

Avoiding Early Cancer Claims. Presentation #4. Hank George, FALU

Avoiding Early Cancer Claims. Presentation #4. Hank George, FALU Avoiding Early Cancer Claims Presentation #4 Hank George, FALU Hematology and High Risk of Early Cancer Claims Mild Anemia in elders is underpriced by insurers most likely because of its high prevalence

More information

Microcytic Hypochromic Anemia An Approach to Diagnosis

Microcytic Hypochromic Anemia An Approach to Diagnosis Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation

More information

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.

More information

Case B14. Pathological WBC counts. Pseudopelger cells

Case B14. Pathological WBC counts. Pseudopelger cells Pathological counts Case B14 Pseudopelger cells Diagnosis: B-PLL An 86-year-old woman treated for breast cancer in 2008 with surgery and postoperative irradiation. Six years later she now consulted her

More information

The ABCs of Waldenström s Macroglobulinemia (WM)

The ABCs of Waldenström s Macroglobulinemia (WM) The ABCs of Waldenström s Macroglobulinemia (WM) Jeffrey V. Matous MD Colorado Blood Cancer Institute IWMF Ed Forum May 2017 Objectives Describe the roots underneath WM Review incidence, possible risk

More information

DR SUDHIR MEHTA MD,MNAMS,FICP. Senior Professor & Head Medical Unit SMS Medical College & Hospital Jaipur

DR SUDHIR MEHTA MD,MNAMS,FICP. Senior Professor & Head Medical Unit SMS Medical College & Hospital Jaipur DR SUDHIR MEHTA MD,MNAMS,FICP Senior Professor & Head Medical Unit SMS Medical College & Hospital Jaipur s.smehta@hotmail.com CBC..What is the Utility of performing this basic Hematology Test? 10/31/2010

More information

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features

More information

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Leukemias Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Introduction Leukaemias are malignant disorders of the haematopoietic stem cell compartment,

More information

Approach to a pale child

Approach to a pale child Approach to a pale child Dr. Dafalla Ahmed Babiker Jazan university objectives Definition of anemia Classification and causes Important points in history and physical examination Investigations. Definition

More information

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA Trish Hyland, Medical Scientist, Department of Haematology, Cork University Hospital

More information

Haematology for GP's

Haematology for GP's Haematology for GP's Dr Christina Zouvelou Consultant Haematologist SOUTHEND UNIVERSITY HOSPITALS NHS FT SPIRE WELLESLEY HOSPITAL Time to Learn, 03/07/2018 Anaemia Careful history (duration, symptoms,

More information

Faculty of Medicine Dr. Tariq Aladily

Faculty of Medicine Dr. Tariq Aladily Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin

More information

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009 LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of

More information

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). MYELOPROLIFARATIVE NEOPLASMS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). These are a group of chronic conditions characterised by clonal proliferation of marrow precursor cells. PRV, essential thrombocyathaemia,

More information

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements

More information

Classification of Anaemia

Classification of Anaemia Classification of Anaemia Dr Roger Pool Department of Haematology NHLS & University of Pretoria MEASUREMENT OF HAEMATOCRIT The haematocrit ratio (Hct) is the proportion of blood made up of cells - mainly

More information

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 ก ก. ก ก.. ก (anemia) ก hemoglobin concentration, hematocrit ก ก ก 2 Standard deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 Hemoglobin hematocrit MCV (g/dl) (%) (fl) ( ) 0.5-1.9

More information

Forms Revision: Myeloma Changes

Forms Revision: Myeloma Changes Sharing knowledge. Sharing hope. Forms Revision: Myeloma Changes J. Brunner, PA-C and A. Dispenzieri, MD February 2013 Disclosures Janet Brunner, PA-C I have no relevant conflicts of interest to disclose.

More information

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS Presenter- Dr. Meghana B S Prof Dr. NAGARAJA B S Prof Dr. NIRMALA A C Dr. SIVARANJANI H Dr. B C PRAKASH Dr. MUMTAZ ALI KHAN A 60 year old lady, k/c/o

More information

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Types of Anaemias and their Management S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Objectives At the end of the presentations participants should be able to: 1. Define

More information

Hematology: Challenging Cases with Your Participation COPYRIGHT

Hematology: Challenging Cases with Your Participation COPYRIGHT Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Question 1 Question 1 64-year-old man is evaluated during

More information

Criteria for Disease Assessment Joan Bladé

Criteria for Disease Assessment Joan Bladé Criteria for Disease Assessment Joan Bladé Unidad de Amiloidosis y Mieloma Servicio de Hematología Hospital Clínic de Barcelona COMy Meeting, París, May 4th, 2018 Response Evaluation EBMT, 1998 - CR and

More information

Anemia In the Insurance Applicant What do the numbers mean?

Anemia In the Insurance Applicant What do the numbers mean? Anemia In the Insurance Applicant What do the numbers mean? Lisa Duckett, M.D. Vice President and Medical Director September 12, 2017 Goals of the presentation Develop a consistent way to analyze Complete

More information

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital Morphology Case Study Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital 41 year old male presented to GP for routine check-up in May 2011. FBC Results:

More information

BONE MARROW PERIPHERAL BLOOD Erythrocyte

BONE MARROW PERIPHERAL BLOOD Erythrocyte None Disclaimer Objectives Define anemia Classify anemia according to pathogenesis & clinical significance Understand Red cell indices Relate the red cell indices with type of anemia Interpret CBC to approach

More information

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016 Disclosures/COI Cases in Hematopathology Vamsi Kota Assistant Professor Department of Hematology & Medical Oncology Leukemia/BMT I have no disclosures or conflicts of interest regarding this presentation.

More information

Red cell disorder. Dr. Ahmed Hasan

Red cell disorder. Dr. Ahmed Hasan Red cell disorder Dr. Ahmed Hasan Things to be learned in this lecture Definition and clinical feature of anemia. Classification of anemia. Know some details of microcytic anemia Question of the lecture:

More information

CSP. Common Sense Pathology CONTENTS. Role of the FBC How to interpret results Value of the blood film

CSP. Common Sense Pathology CONTENTS. Role of the FBC How to interpret results Value of the blood film CSP Common Sense Pathology APRIL 2004 A REGULAR CASE-BASED SERIES ON PRACTICAL PATHOLOGY FOR GPs CONTENTS Role of the FBC How to interpret results Value of the blood film A JOINT INITIATIVE OF The Royal

More information

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Preferred Clinical Services for Leading Age Florida August 26-27, 2015 DIAGNOSIS CODING ESSENTIALS FOR LONG-TERM CARE: CHAPTER 3, D CODES DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS AND CERTAIN DISORDERS INVOLVING THE IMMUNE MECHANISM Preferred Clinical Services for Leading

More information

Laboratory Examination

Laboratory Examination Todd Zimmerman, M.D. 64 year old African American male presents to establish care with PCG. Meds: Norvasc 5 mg daily PMHx: HTN x 20 years, poorly controlled SHx: No tobacco, illicit; rare EtOH ROS: Negative

More information

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock Learning Objectives At the completion of this program, the participants will be able to: 1. Identify the components of the CBC and Differential and their clinical implications. 2. Identify normal pediatric

More information

Kathleen Finnegan MS MT(ASCP)SHCM

Kathleen Finnegan MS MT(ASCP)SHCM Kathleen Finnegan MS MT(ASCP)SHCM Discuss the history of hematology automation and digital differentials. Discuss the HemoFAXS Hematology Analysis System by Tissue Gnostics. Review automated microscopy

More information

GP Education Haematology laboratory abnormalities- when to refer? Priyanka Mehta Consultant Haematologist UH Bristol NHS Trust

GP Education Haematology laboratory abnormalities- when to refer? Priyanka Mehta Consultant Haematologist UH Bristol NHS Trust GP Education Haematology laboratory abnormalities- when to refer? Priyanka Mehta Consultant Haematologist UH Bristol NHS Trust Topics for discussion Abnormal FBCs Lymphocytosis high and low platelets cytopenias

More information

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms We've one category for lymphoid neoplasm which is the lymphoma in contrast to that of myeloid which has three categories; acute myeloid leukemias, myeloproliferative & myelodysplastic disorders. Lymphoma

More information

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases) Table 8.1. Epidemiology of Leukemia in the United States (2010) Type of Leukemia Annual Incidence (Number of New Cases) Percentage of All Leukemias (%) Annual Deaths Mean Age Acute lymphocytic 5,330 12

More information

Should we treat Smoldering MM patients? María-Victoria Mateos University Hospital of Salamanca Salamanca. Spain

Should we treat Smoldering MM patients? María-Victoria Mateos University Hospital of Salamanca Salamanca. Spain Should we treat Smoldering MM patients? María-Victoria Mateos University Hospital of Salamanca Salamanca. Spain Should we treat some patients with Stage I MM? Len-dex is a promising and atractive option

More information

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

Management Update: Multiple Myeloma. Presented by Prof. Dr. Khan Abul Kalam Azad Professor of Medicine Dhaka Medical College

Management Update: Multiple Myeloma. Presented by Prof. Dr. Khan Abul Kalam Azad Professor of Medicine Dhaka Medical College Management Update: Multiple Myeloma Presented by Prof. Dr. Khan Abul Kalam Azad Professor of Medicine Dhaka Medical College Introduction Multiple myeloma - clonal plasma cell neoplasm Monoclonal antibody

More information